Compile Data Set for Download or QSAR
Report error Found 12 Enz. Inhib. hit(s) with all data for entry = 8914
TargetBombesin receptor subtype-3(Human)
Seldar Pharma

US Patent
LigandPNGBDBM428851(US10532048, Example 236)
Affinity DataIC50: 3nMAssay Description:A BB2 receptor binding test was carried out using a membrane sample prepared from a human prostate cancer-derived PC-3 cell. The PC-3 cell was cultur...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetBombesin receptor subtype-3(Human)
Seldar Pharma

US Patent
LigandPNGBDBM428855(US10532048, Example 631)
Affinity DataIC50: 4.5nMAssay Description:A BB2 receptor binding test was carried out using a membrane sample prepared from a human prostate cancer-derived PC-3 cell. The PC-3 cell was cultur...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetBombesin receptor subtype-3(Human)
Seldar Pharma

US Patent
LigandPNGBDBM428852(US10532048, Example 542)
Affinity DataIC50: 4.70nMAssay Description:A BB2 receptor binding test was carried out using a membrane sample prepared from a human prostate cancer-derived PC-3 cell. The PC-3 cell was cultur...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetBombesin receptor subtype-3(Human)
Seldar Pharma

US Patent
LigandPNGBDBM428853(US10532048, Example 560)
Affinity DataIC50: 4.80nMAssay Description:A BB2 receptor binding test was carried out using a membrane sample prepared from a human prostate cancer-derived PC-3 cell. The PC-3 cell was cultur...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetBombesin receptor subtype-3(Human)
Seldar Pharma

US Patent
LigandPNGBDBM428854(US10532048, Example 589)
Affinity DataIC50: 5.70nMAssay Description:A BB2 receptor binding test was carried out using a membrane sample prepared from a human prostate cancer-derived PC-3 cell. The PC-3 cell was cultur...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetBombesin receptor subtype-3(Human)
Seldar Pharma

US Patent
LigandPNGBDBM428856(US10532048, Example 700)
Affinity DataIC50: 6.70nMAssay Description:A BB2 receptor binding test was carried out using a membrane sample prepared from a human prostate cancer-derived PC-3 cell. The PC-3 cell was cultur...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetBombesin receptor subtype-3(Human)
Seldar Pharma

US Patent
LigandPNGBDBM428859(US10532048, Example 712)
Affinity DataIC50: 6.70nMAssay Description:A BB2 receptor binding test was carried out using a membrane sample prepared from a human prostate cancer-derived PC-3 cell. The PC-3 cell was cultur...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetBombesin receptor subtype-3(Human)
Seldar Pharma

US Patent
LigandPNGBDBM428860(US10532048, Example 856)
Affinity DataIC50: 6.80nMAssay Description:A BB2 receptor binding test was carried out using a membrane sample prepared from a human prostate cancer-derived PC-3 cell. The PC-3 cell was cultur...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetBombesin receptor subtype-3(Human)
Seldar Pharma

US Patent
LigandPNGBDBM428857(US10532048, Example 701)
Affinity DataIC50: 7.40nMAssay Description:A BB2 receptor binding test was carried out using a membrane sample prepared from a human prostate cancer-derived PC-3 cell. The PC-3 cell was cultur...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetBombesin receptor subtype-3(Human)
Seldar Pharma

US Patent
LigandPNGBDBM428858(US10532048, Example 709)
Affinity DataIC50: 8.90nMAssay Description:A BB2 receptor binding test was carried out using a membrane sample prepared from a human prostate cancer-derived PC-3 cell. The PC-3 cell was cultur...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetBombesin receptor subtype-3(Human)
Seldar Pharma

US Patent
LigandPNGBDBM428841(US10532048, Example 61)
Affinity DataIC50: 12.8nMAssay Description:A BB2 receptor binding test was carried out using a membrane sample prepared from a human prostate cancer-derived PC-3 cell. The PC-3 cell was cultur...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetBombesin receptor subtype-3(Human)
Seldar Pharma

US Patent
LigandPNGBDBM428850(US10532048, Example 62)
Affinity DataIC50: 18.3nMAssay Description:A BB2 receptor binding test was carried out using a membrane sample prepared from a human prostate cancer-derived PC-3 cell. The PC-3 cell was cultur...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent